You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M MEBROFENIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TECHNETIUM TC-99M MEBROFENIN

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00767468 ↗	Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis	Terminated	National Cancer Institute (NCI)	Phase 1	2008-10-01	RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib in treating patients with locally advanced or metastatic liver cancer and cirrhosis.
NCT00767468 ↗	Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis	Terminated	UNC Lineberger Comprehensive Cancer Center	Phase 1	2008-10-01	RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib in treating patients with locally advanced or metastatic liver cancer and cirrhosis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TECHNETIUM TC-99M MEBROFENIN

Condition Name

Chart
Table

Condition Name for TECHNETIUM TC-99M MEBROFENIN
Intervention	Trials
Liver Cancer	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TECHNETIUM TC-99M MEBROFENIN
Intervention	Trials
Liver Neoplasms	1
Carcinoma, Hepatocellular	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TECHNETIUM TC-99M MEBROFENIN

Trials by Country

Map
Table

Trials by Country for TECHNETIUM TC-99M MEBROFENIN
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TECHNETIUM TC-99M MEBROFENIN
Location	Trials
North Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TECHNETIUM TC-99M MEBROFENIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TECHNETIUM TC-99M MEBROFENIN
Clinical Trial Phase	Trials
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TECHNETIUM TC-99M MEBROFENIN
Clinical Trial Phase	Trials
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TECHNETIUM TC-99M MEBROFENIN

Sponsor Name

Chart
Table

Sponsor Name for TECHNETIUM TC-99M MEBROFENIN
Sponsor	Trials
National Cancer Institute (NCI)	1
UNC Lineberger Comprehensive Cancer Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TECHNETIUM TC-99M MEBROFENIN
Sponsor	Trials
NIH	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.